medicaid cover semaglutide Rhode Island considers ending coverage of GLP-1 drugs for weight loss • Rhode Island Current Medicaid Covers GLP-1 Meds for

Hin vn cha c thuc gii c c hiu

What to Watch Out For: Unproven GLP-1 Patch Claims The growing popularity of GLP-1 medications for weight management has unfortunately created opportunities for fraudulent products and misleading marketing

Stopping treatment due to early nausea means missing the benefit of a medication that works well for most people after the adaptation phase

**The views, opinions, and recommendations expressed in this essay are solely my own and do not represent the views, policies, or positions of my employer or any other organization with which I am affiliated

Current Phase 3 trials (expected to report results in 2027) are exploring doses ranging from 4mg to 12mg weekly, with some protocols testing up to 16mg

Many doctors offices have these products available